These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33098359)

  • 1. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
    Zeng HL; Chen D; Yan J; Yang Q; Han QQ; Li SS; Cheng L
    FEBS J; 2021 Sep; 288(17):5190-5200. PubMed ID: 33098359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection.
    Mukherjee S; Banerjee B; Karasik D; Frenkel-Morgenstern M
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples.
    Okendo J; Musanabaganwa C; Mwangi P; Nyaga M; Onywera H
    PLoS One; 2022; 17(8):e0271870. PubMed ID: 35939435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
    Kitsou K; Kotanidou A; Paraskevis D; Karamitros T; Katzourakis A; Tedder R; Hurst T; Sapounas S; Kotsinas A; Gorgoulis V; Spoulou V; Tsiodras S; Lagiou P; Magiorkinis G
    Microbiol Spectr; 2021 Oct; 9(2):e0126021. PubMed ID: 34612698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia.
    Nguyen EV; Gharib SA; Palazzo SJ; Chow YH; Goodlett DR; Schnapp LM
    PLoS One; 2013; 8(3):e58782. PubMed ID: 23505561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.
    Ortea I; Rodríguez-Ariza A; Chicano-Gálvez E; Arenas Vacas MS; Jurado Gámez B
    J Proteomics; 2016 Apr; 138():106-14. PubMed ID: 26917472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
    Lin FC; Chen YC; Chang SC
    Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.
    Nossent EJ; Schuurman AR; Reijnders TDY; Saris A; Jongerius I; Blok SG; de Vries H; Duitman J; Vonk Noordegraaf A; Meijboom LJ; Lutter R; Heunks L; Bogaard HJ; van der Poll T
    Front Immunol; 2021; 12():664209. PubMed ID: 34054832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis of bronchoalveolar lavage fluids from patients with small cell lung cancers.
    Vu HM; Mohammad HB; Nguyen TNC; Lee JH; Do Y; Sung JY; Lee SH; Kim MS
    Proteomics Clin Appl; 2023 Sep; 17(5):e2300011. PubMed ID: 36807835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung Cancers.
    Sim SY; Choi YR; Lee JH; Lim JM; Lee SE; Kim KP; Kim JY; Lee SH; Kim MS
    Proteomics Clin Appl; 2019 Sep; 13(5):e1900028. PubMed ID: 31119868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.
    Nguyen EV; Gharib SA; Crothers K; Chow YH; Park DR; Goodlett DR; Schnapp LM
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L35-42. PubMed ID: 24213920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples.
    Biji A; Khatun O; Swaraj S; Narayan R; Rajmani RS; Sardar R; Satish D; Mehta S; Bindhu H; Jeevan M; Saini DK; Singh A; Gupta D; Tripathi S
    EBioMedicine; 2021 Aug; 70():103525. PubMed ID: 34392148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patients.
    Voiriot G; Dorgham K; Bachelot G; Fajac A; Morand-Joubert L; Parizot C; Gerotziafas G; Farabos D; Trugnan G; Eguether T; Blayau C; Djibré M; Elabbadi A; Gibelin A; Labbé V; Parrot A; Turpin M; Cadranel J; Gorochov G; Fartoukh M; Lamazière A
    Sci Rep; 2022 Jun; 12(1):9502. PubMed ID: 35681070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Wu M; Chen Y; Xia H; Wang C; Tan CY; Cai X; Liu Y; Ji F; Xiong P; Liu R; Guan Y; Duan Y; Kuang D; Xu S; Cai H; Xia Q; Yang D; Wang MW; Chiu IM; Cheng C; Ahern PP; Liu L; Wang G; Surana NK; Xia T; Kasper DL
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28336-28343. PubMed ID: 33082228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
    J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of Pulmonary Responses in Severe COVID-19.
    Wu D; Yang XO
    Viruses; 2021 May; 13(6):. PubMed ID: 34064104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 early infection signature identified potential key infection mechanisms and drug targets.
    Li Y; Duche A; Sayer MR; Roosan D; Khalafalla FG; Ostrom RS; Totonchy J; Roosan MR
    BMC Genomics; 2021 Feb; 22(1):125. PubMed ID: 33602138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.